R. Davila et al., CHANGES IN PLASMA DIHYDROXYPHENYLACETIC ACID DURING HALOPERIDOL TREATMENT OF PATIENTS WITH SCHIZOPHRENIA, The European journal of psychiatry, 8(3), 1994, pp. 187-190
Plasma dihydroxyphenylacetic acid (pDOPAC) was determined in 48 young
patients with schizophrenia before and during four weeks of treatment
with haloperidol. We have not observed any clear effects of haloperido
l on the levels of pDOPAC. We did not find any correlation between bas
al values of DOPAC or changes in the concentrations of DOPAC and clini
cal outcome.